Fingerprint
Dive into the research topics of 'Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose-escalation, dose-expansion, phase 1–2 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically